FDA Authorizes 3rd Dose of Pfizer Vaccine for Immunocompromised Kids — Children's Cancer Cause
Who Didn't Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines | KFF
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
Real world' study shows Pfizer and Moderna vaccines were 90% effective
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors | Nature Communications
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
Covid: Gap between Pfizer vaccine doses should be halved, say doctors - BBC News
Moderna vaccine slightly more effective than Pfizer vaccine in preventing COVID-19 infection, hospitalization, and death | News | Harvard T.H. Chan School of Public Health
What is the evidence for extending the SARS-CoV-2 (COVID-19) vaccine dosing schedule? | British Columbia Medical Journal
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection | NEJM
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Changing the UK COVID-19 vaccine dosing schedule - POST
expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science
Evaluation of COVID-19 vaccination strategies with a delayed second dose | medRxiv
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
